FDA, NIAID and CDC are announcing a public workshop regarding the development considerations of antimicrobial drugs for the treatment of gonorrhea. The workshop will focus on the current state and nonclinical and clinical trial design considerations regarding antimicrobial drug development for gonorrhea and include the following topic areas:

• Animal models
• Clinical pharmacology considerations
• Trial design considerations for gonorrhea, such as enrollment strategies, choice of comparators and site of infection.

This meeting will be held in virtual format only. Registration is required for online attendance.

To learn more, click here.
Additional details forthcoming.